Organization Profile

You just read:

International Clinical Steering Committee Announced for Resverlogix's Phase 3 BETonMACE Clinical Trial with RVX-208 "apabetalone"

News provided by

Resverlogix Corp.

Aug 04, 2015, 07:30 ET